From Next Big Future:
Aging Expert Heading FDA Could be Good for Antiaging Projects
In April, aging research expert Norman E. (Ned) Sharpless, MD will become the acting commissioner of the Food and Drug Administration. Dr. Sharpless is a 2003 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar. Ned served on AFAR’s National Scientific Advisory Council from 2005-2011 and chaired the Selection Committee of the Glenn/AFAR Postdoctoral Program for Transnational Research on Aging program in 2015 and 2016. For over 30 years, AFAR has supported the science of healthier aging.
Great call (from my perspective of 68 orbits around our sun).
Leave a comment